Bank of New Hampshire’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$177K Hold
1,400
0.04% 206
2026
Q1
$195K Hold
1,400
0.04% 196
2025
Q4
$172K Hold
1,400
0.04% 197
2025
Q3
$155K Hold
1,400
0.04% 208
2025
Q2
$155K Hold
1,400
0.04% 210
2025
Q1
$157K Sell
1,400
-1,365
-49% -$141K 0.04% 201
2024
Q4
$255K Hold
2,765
0.07% 165
2024
Q3
$232K Hold
2,765
0.06% 177
2024
Q2
$190K Hold
2,765
0.05% 196
2024
Q1
$203K Hold
2,765
0.05% 194
2023
Q4
$224K Hold
2,765
0.06% 180
2023
Q3
$207K Hold
2,765
0.06% 185
2023
Q2
$213K Hold
2,765
0.06% 187
2023
Q1
$229K Sell
2,765
-600
-18% -$49.7K 0.07% 179
2022
Q4
$289K Hold
3,365
0.09% 166
2022
Q3
$208K Hold
3,365
0.07% 183
2022
Q2
$208K Hold
3,365
0.06% 189
2022
Q1
$200K Buy
3,365
+600
+22% +$38.4K 0.05% 204
2021
Q4
$201K Buy
+2,765
New +$190K 0.05% 200

Other funds holding GILD

Bank of New Hampshire's GILD Position: Q2 2026 in Review

Bank of New Hampshire held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,400 shares worth $177K. The position accounts for 0.04% of the portfolio, ranked #206.

Bank of New Hampshire first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $289K in Q4 2022. 1,509 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bank of New Hampshire held 1,400 shares of Gilead Sciences worth $177K as of Q2 2026.
  • Bank of New Hampshire left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Bank of New Hampshire's portfolio in Q2 2026, its #206 holding.
  • Bank of New Hampshire first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Bank of New Hampshire's Gilead Sciences position peaked at $289K in Q4 2022.
  • 1,509 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.